| 1. | 肖永紅, 沈萍, 魏澤慶, 等.Mohnarin 2010年度全國細菌耐藥監測.中華醫院感染學雜志, 2011, 21:4896-4902. | 
				                                                        
				                                                            
				                                                                | 2. | Hotchkiss RS, Monneret G, Payen D.Sepsis-induced immunosuppression:from cellar dysfunction to immunotherapy.Nat Rev Immunol, 2013, 13:862-874. | 
				                                                        
				                                                            
				                                                                | 3. | Okazaki T, Honjo T.PD-1 and PD-1 ligands:from discovery to clinical application.Int Immunol, 2007, 19:813-824. | 
				                                                        
				                                                            
				                                                                | 4. | 郭國寧, 謝諄怡, 陳永文.共抑制分子PD-1的研究進展.免疫學雜志, 2010, 26:639-642. | 
				                                                        
				                                                            
				                                                                | 5. | Powles T, Eder JP, Fine GD, et al.MPDL3280A(anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer.Nature, 2014, 515:558-562. | 
				                                                        
				                                                            
				                                                                | 6. | Said EA, Dupuy FP, Trautmann L, et al.Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection.Nat Med, 2010, 16:452-459. | 
				                                                        
				                                                            
				                                                                | 7. | Huang X, Chen Y, Chung CS, et al.Identification of B7-H1 as a novel mediator of the innate immune/proinflammatory response as well as a possible myeloid cell prognostic biomarker in sepsis.J Immunol, 2014, 192:1091-1099. | 
				                                                        
				                                                            
				                                                                | 8. | 劉茜, 陸江陽, 王曉虹, 等.MODS小鼠脾臟樹突細胞PD-1、PD-L1的表達變化及其意義.解放軍醫學雜志, 2010, 35:17-19. | 
				                                                        
				                                                            
				                                                                | 9. | Zhang Y, Li J, Lou J, et, al.Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients.Crit Care, 2011, 15:R70. | 
				                                                        
				                                                            
				                                                                | 10. | Guignant C, Lepape A, Huang X, et al.Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients.Crit Care, 2011, 15:R99. | 
				                                                        
				                                                            
				                                                                | 11. | Rittirsch D, Huber-Lang MS, Flierl MA, et al.Immunodesign of experimental sepsis by cecal ligation and puncture.Nat Protoc, 2009, 4:31-36. | 
				                                                        
				                                                            
				                                                                | 12. | Singleton KD, Wischmeyer PE.Distance of cecum ligated influences mortality, tumor necrosis factor-alpha and interleukin-6 expression following cecal ligation and puncture in the rat.Eur Surg Res, 2003, 35:486-491. |